- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05074030
EMA/EMI for Psychiatrically Hospitalized Emerging Adults Who Drink to Cope
Project CHOICE: Developing a Personalized-Feedback EMA/EMI Intervention for Emerging Adults Leaving Psychiatric Partial Hospitalization
Study Overview
Status
Conditions
Detailed Description
Given the relationship between mental health and alcohol problems, there is a need to address comorbidity among emerging adults (EAs) with anxiety and/or depression. The weeks after psychiatric hospitalization are a risky time for problematic alcohol use and recurrence of psychiatric symptoms. The delivery of tailored, coping skills-based, real-time messages could have a significant impact on problematic drinking and depression/anxiety outcomes by reducing the likelihood that an individual drinks to cope with NA.
The aim of this study is to test a 6-week PFIcope+EMI intervention as compared to personalized normative feedback only (PNF) for EA in a partial hospitalization program who drink to cope and binge drink (n=60). The PFIcope+EMI includes: 1) an in-person personalized feedback session to present feedback on problems with drinking to cope, discuss the individual's use of alcohol to cope, and generate coping skills messages to be used in the EMI intervention; 2) EMA to monitor affect, intention to drink, coping skills usage, alcohol use, drinking to cope post-discharge; 3) tailored text messages (EMI) based on EMA (individualized coping skills messages when NA and intention to drink are reported). The Personalized Normative Feedback condition (PNF) will receive a personalized normative feedback report but no EMA or EMI.
Participants' alcohol outcomes and psychiatric symptomatology at 6-weeks, 12-weeks, and 6-months will be assessed to determine outcomes and feasibility/acceptability. It is hypothesized that:
- Individuals in PFIcope+EMI arm will report between-subjects reductions in drinking to cope, alcohol use, alcohol-related problems, and NA as compared to PNF.
- PFIcope+EMI will be feasible to implement and result in high rates of participant satisfaction.
Mechanisms that may underlie the efficacy of the intervention for the PFIcope+EMI group utilizing the daily EMA data will be explored. It is hypothesized that:
- In response to NA, participants will report an increase in coping skills utilization and decreased intent to drink at the following EMA assessment point.
- NA reductions and increased coping skills utilization will be related to improvements in alcohol use rates and problems at the following EMA assessment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- Butler Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- between 18 and 25 years of age
- reported alcohol use at least 3x weekly over past month and at least one day per week, on average, of binge drinking (as defined as 4+ drinks/2 hours for men and 3+ drinks/2 hours for women)
- self-reported use of coping motive (mean of 2+ on coping subscale of MDMQ-R, indicating they drink to cope at least "some of the time")
- current anxiety and/or depression symptomatology (as assessed CES-D scores above cut-off for high risk for clinical depression and GAD-7 scores above cut-off for moderate to severe anxiety)
- owns a smartphone capable of downloading EMA app.
Exclusion Criteria:
- current DSM-5 diagnosis of moderate/severe substance use disorder (other than alcohol, cannabis, or nicotine) as assessed by research staff via SCID
- a history of psychotic disorder or current psychotic symptoms as assessed by research staff via SCID
- current suicidal/homicidal ideation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: PNF
Participants in the PNF condition will receive normative feedback only on their alcohol use.
|
Normative Feedback on drinking behaviors.
|
|
Experimental: PFIcope+EMI
The 6-week PFIcope+EMI includes: 1) an in-person personalized feedback session to present feedback on problems with drinking to cope, discuss the individual's use of alcohol to cope, and generate coping skills messages to be used in the EMI intervention; 2) EMA to monitor affect, intention to drink, coping skills usage, alcohol use, drinking to cope post-discharge; 3) tailored text messages (EMI) based on EMA (individualized coping skills messages when NA and intention to drink are reported).
|
An EMA plus EMI intervention to decrease drinking to cope behaviors among emerging adults receiving psychiatric treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Drinks per Drinking Days
Time Frame: 6-week follow-up
|
Drinks per drinking day assessed using the Timeline Followback (TLFB)
|
6-week follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Drinking Motives
Time Frame: 6-week follow-up
|
Mean Scores on the Drinking to Cope subscale of the Modified Drinking Motives Questionnaire (range from 5 to 25; higher values reflect greater drinking to cope)
|
6-week follow-up
|
|
Alcohol-related problems
Time Frame: 6-week follow-up
|
Number of consequences of alcohol use assessed with the Rutgers Alcohol Problems Index
|
6-week follow-up
|
|
Alcohol Outcome Expectancies
Time Frame: 6-week follow-up
|
The number of benefits and costs associated with changing drinking behaviors as measured by the Alcohol Outcome Expectancies Questionnaire
|
6-week follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Drinks per Drinking Days
Time Frame: 12-week follow-up
|
Drinks per drinking day assessed using the Timeline Followback (TLFB)
|
12-week follow-up
|
|
Drinks per Drinking Days
Time Frame: 6-month follow-up
|
Drinks per drinking day assessed using the Timeline Followback (TLFB)
|
6-month follow-up
|
|
Drinking Motives
Time Frame: 12-week follow-up
|
Mean Scores on the Drinking to Cope subscale of the Modified Drinking Motives Questionnaire (range from 5 to 25; higher values reflect greater drinking to cope)
|
12-week follow-up
|
|
Drinking Motives
Time Frame: 6-month follow-up
|
Mean Scores on the Drinking to Cope subscale of the Modified Drinking Motives Questionnaire (range from 5 to 25; higher values reflect greater drinking to cope)
|
6-month follow-up
|
|
Alcohol-related problems
Time Frame: 12-week follow-up
|
Number of consequences of alcohol use assessed with the Rutgers Alcohol Problems Index
|
12-week follow-up
|
|
Alcohol-related problems
Time Frame: 6-month follow-up
|
Number of consequences of alcohol use assessed with the Rutgers Alcohol Problems Index
|
6-month follow-up
|
|
Alcohol Outcome Expectancies
Time Frame: 12-week follow-up
|
The number of benefits and costs associated with changing drinking behaviors as measured by the Alcohol Outcome Expectancies Questionnaire
|
12-week follow-up
|
|
Alcohol Outcome Expectancies
Time Frame: 6-month follow-up
|
The number of benefits and costs associated with changing drinking behaviors as measured by the Alcohol Outcome Expectancies Questionnaire
|
6-month follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ana M Abrantes, Ph.D., Butler Hospital/Alpert Medical School of Brown University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2104-001
- R34AA028572 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorder
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Methamphetamine-dependence | Substance Use Disorders | Cocaine Use Disorder | Alcohol Use Disorder (AUD) | Cannabis Use Disorder | Amphetamine Use DisorderGermany
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
University of BernRecruitingAlcohol Use Disorder (AUD) | Substance Use Disorder (SUD) | Cocaine Use Disorder (CUD)Switzerland
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of Wisconsin, MadisonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingAlcohol Use Disorder | Alcohol Use Disorder (AUD)United States
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...RecruitingAlcohol Drinking | Substance Use | Alcohol Use Disorder | Drinking, Alcohol | Alcohol Use Disorder (AUD)United States
-
ITAB - Institute for Advanced Biomedical TechnologiesNot yet recruitingNeurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use DisorderAlcohol Dependence | Alcohol-Related Disorders | Substance Use Disorders | Drug Abuse | Mental Disorder | Alcohol Abuse | Alcohol Use Disorder (AUD)
Clinical Trials on Personalized Normative Feedback
-
Universidad Miguel Hernandez de ElcheMinisterio de Derechos Sociales, Consumo y Agenda 2030, SpainCompleted
-
University of HoustonCompletedHeavy DrinkingUnited States
-
University of HoustonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Duquesne UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol ConsumptionUnited States
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruiting
-
Federal University of São PauloCompleted
-
Loyola Marymount UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Drinking | Alcohol; Harmful Use | Alcohol AbuseUnited States
-
RANDUniversity of Southern CaliforniaCompleted
-
RANDNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAOD Misuse | AOD Associated ConsequencesUnited States
-
University of HoustonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)UnknownAlcohol Consumption